-
Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR. Bone Marrow Transplant, 53(4): 478-482, 2018. doi: 10.1038/s41409-017-0028-x
Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihana K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y.
-
A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. European Journal of Haematology, 100(4): 335-343, 2018. doi: 10.1111/ejh
Okada M, Tasaka T, Ikegame K, Aotsuka N, Kobayashi T, Najima Y, Matsuhashi Y, Wada H, Tokunaga H, Masuda S, Utsu Y, Yoshihara S, Kaida K, Daimon T, Ogawa H.
-
Spousal hematopoietic stem cell transplantation. Int J Hematol, 105(5): 646-657, 2017. 10.1007/s12185-016-2168-y
Ikegame K, Kaida K, Yoshihara S, Yoshihara K, Ishii S, Inoue T, Okada M, Tamaki H, Soma T, Kusunoki Y, Kojima H, Saji H, Ogawa H.
-
Host Foxp3+CD4+ regulatory T cells act as a negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology, 196: 469-483, 2016. doi: 10.4049/jimmunol.1402950.
Inoue T, Ikegame K, Kaida K, Okada M, Yoshihara S, Tamaki H, Fujimori Y, Soma T, Ogawa H.
-
Unmanipulated haploidentical RIST using fludarabine, busulfan, low- dose ATG and steroid for patients in non-CR or at high risk of relapse: a prospective multicenter phase I/II study in Japan. Biology of Blood and Marrow Transplantation, 21: 1495-1505, 2015.
Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, Ueda Y, Kaida K, Ishii S, Taniguchi K, Okada M, Tamaki H, Okumura H, Kaya H, Kurokawa T, Kodera Y, Taniguchi S, Kanda Y, Ogawa H.
-
Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced intensity conditioning. International Journal of Hematology, 99: 463-470, 2014.
*Kaida K, *Ikegame K, Ikemoto J, Murata R, Irie R, Yoshihara S, Ishii S, Okada M, Inoue T, Tamaki H, Soma T, Fujimori Y, Kai S, Ogawa H.
-
Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. Bone Marrow Transplant, 48: 859-864, 2013.
Fujioka T, Tamaki H, Ikegame K, Yoshihara S, Taniguchi K, Kaida K, Kato R, Inoue T, Nakata J, Ishii S, Soma T, Okada M, Ogawa H.
-
Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. International Journal of Hematology, 96; 101-108, 2012.
Ikegame K, Kaida K, Yoshihara S, Fujiwara M, Taniguchi K, Kato R, Inoue T, Fujioka T, Tamaki H, Okada M, Soma T, Kamikonya N, Saji H, Hirota S, Ogawa H.
-
Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study. Biology of Blood and Marrow Transplantation, 18; 633-639, 2012.
Okada M, Yoshihara S, Taniguchi K, Kaida K, Ikegame K, Kato R, Tamaki H, Inoue T, Soma T, Kai S, Kato S, Ogawa H.
-
Allogeneic stem cell transplantation as treatment for heavily-treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. Experimental Hematology, 39; 880-890, 2011.
Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H.
-
Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. International Journal of Hematology, 91: 485-497, 2010.
Satake A, Inoue T, Kubo S, Taniguchi Y, Imado T, Fujioka T, Horiuchi M, Xu Y, Ikegame K, Yoshihara S, Kaida K, Tamaki H, Okada M, Okamura H, Ogawa H.
-
Recovery from established graft-versus-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Experimental Hematology, 36:1216-1225, 2008.
Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K, Kawakami M, Masuda T, Aozasa K, Kawase I, Ogawa H.
-
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Experimental Hematology, 36: 1-8, 2008.
Ogawa H, Ikegame K, Kaida K, Yoshihara S, Fujioka T, Taniguchi Y, Tamaki H, Inoue T, Hasei H, Iiboshi Y, Tazuke Y, Kawakami M, Kim EH, Soma T, Inoue T and Kawase I.
-
A Novel Direct Competitive Repopulation Assay For Human Hematopoietic Stem Cells Using NOD/SCID Mice. Cytotherapy, 8: 390-398, 2006.
Tatekawa T, Ogawa H, Kawakami M, Oka Y, Yasukawa K, Sugiyama H, Kawase I, and Soma T.
-
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 12: 1073-1084, 2006.
Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
-
HLA-haploidentical nonmyeloablative stem cell transplantation: Induction to tolerance without passing through mixed chimerism. Clinical and Laboratory Haematology, 27: 1-3, 2005.
Ikegame K, Kawakami M, Yamagami T, Maeda H, Onishi K, Taniguchi Y, Fujioka T, Masuda T, Kawase I, Ogawa H.
-
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation. Transplantation, 78: 488-489, 2004.
Ogawa H, Ikegame K, Soma T, Kawakami M, Tsuboi A, Kim EH, Hosen N, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Yoshihara S, Tatekawa T, Oji Y, Oka Y, Kawase I.
-
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large–scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. International Journal of Hematology, 79: 495-500, 2004.
Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T, Sao H, Kodera Y, Hirabayashi N, Okamoto S, Harada M, Iwato K, Maruta A, Tanimoto M, Kawa K.
-
Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors. Haematologica, 89: 373-375, 2004. 20. Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, Ikegame K, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Nishida S, Osumi K, Soma T, Oji Y, Oka Y, Kawase I, Sugiyama H, and Ogawa H. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms' tumor gene (WT1). International Journal of Hematology, 78: 349-356, 2003.
Ogawa H, Ikegame K, Kawakami M, Taniguchi Y, Oka Y, and Kawase I.
-
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms' tumor gene (WT1). International Journal of Hematology, 78: 349-356, 2003
Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, Ikegame K, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Nishida S, Osumi K, Soma T, Oji Y, Oka Y, Kawase I, Sugiyama H, and Ogawa H.
-
Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. Leukemia, 17: 2052-2054, 2003.
Tamaki H, Ikegame K, Kawakami M, Fujioka T, Tsuboi A, Oji Y, Oka Y, Sugiyama H, Kawase I, and Ogawa H.
-
Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen. Haematologica, 88: ELT06, 2003.
Taniguchi Y, Ikegame K, Yoshihara S, Sugiyama H, Kawase I, and Ogawa H.
-
The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model. Transplant Immunology, 11: 187-195, 2003.
Fujioka T, Taniguchi Y, Masuda T, Nishida S, Ikegame K, Kawakami M, Tsuboi A, Hosen N, Murakami M, Oji Y, Oka Y, Sugiyama H, Kawase I, and Ogawa H.
-
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood, 101: 1698-1704, 2003.
Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A, Kim EH, Hosen N, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Nishida S, Oji Y, Oka Y and Sugiyama H.
-
The combination of tacrolimus, methotrexate, and methylprednisolone completely prevents acute graft-versus-host disease(GVHD) but not chronic GVHD in unrelated bone marrow transplantation. Transplantation, 74: 236-243, 2002.
Ogawa H, Soma T, Hosen N, Tatekawa T, Tsuboi A, Oji Y, Tamaki H, Kawakami M, Ikegame K, Murakami M, Fujioka T, Kim EH, Oka Y, Sugiyama H.
-
Wilms tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood, 91: 2969-2976, 1998.
Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, Oji Y, Tsuboi A, Kim EH, Kawakami M, Akiyama T, Kishimoto T and Sugiyama H.
-
A high incidence of chemotherapy-induced acral erythema (CAE) in female patients with non-Hodgkin’s lymphoma who were treated with VACOP-B regimen. Leukemia and Lymphoma, 29: 171-177, 1998.
Ogawa H, Sugiyama H, Tani Y, Soma T, Yamagami T, Tatekawa T, Oji Y, Kubota T, Kimura T, Inoue K, Nakagawa M, Sasaki K, Matsunashi T, Miyake S and Kishimoto T.
-
Isolation of cDNA clone encoding a novel membrane protein expressed in lymphocytes. FEBS letters, 355: 30-34, 1994.
Shimizu Y, Ogawa H, Oka Y, Mizuno R, Sakoda S, Kishimoto T and Sugiyama H.
-
No correlation between location of bcr breakpoints and clinical states in Ph1-positive CML patients. Leukemia, 3: 492-496, 1989.
Ogawa H, Sugiyama H, Soma T, Masaoka T and Kishimoto S.
-
Rearrangement of immunoglobulin heavy chain genes and T3 expression in the absence of rearrangement of T-cell receptor -chain gene in a patient with T-cell malignant lymphoma. Leukemia Research, 10: 1369-1375, 1986.
Ogawa H, Sugiyama H, Oka Y, Maeda T, Komori T, Tani Y, Miyake S, Soma T, Maekura R, Yutani C, Masaoka T and Kishimoto S.
